biology. These factors contribute to the limited effectiveness of
current treatment modalities and result
as a potential treatment for FTD. Finally, a review of the
current scientific literature identified 13
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Rakhimova, Ellina M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Jonas, Jost B. (2025) .26), with adjusting for older age (OR: 1.08), male sex (OR: 4.18), higher waist-hip ratio (OR: 5.53),
current smoking
Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) for innovative precision therapies. This review examines the
current state of targeted therapies for intracranial
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) and epigenetic disorders. MicroRNAs are
currently considered one of the most promising prognostic and diagnostic
strategies that go beyond managing symptoms to actively promote brain repair and functional recovery.
Current